Measurements of free thyroxine (FT 4 ) and free triiodothyronine (FT 3 ) are important for the diagnosis and monitoring of thyroid diseases. Considerable differences among methods limit their clinical utility, however, and accurate methods are needed for various clinical specimens. We describe a direct equilibrium dialysis (ED)-liquid chromatography (LC)/ tandem mass spectrometry (MS/MS) method for FT 4 and FT 3 .
; 3,3Ј,5-triiodo-Lthyronine, T 3 ) that are essential for normal development and maintenance of normal physiological functions (1, 2 ) . It is generally accepted that only free hormones in circulation are metabolically active (3) (4) (5) (6) . Their measurement is useful for clinical diagnosis of thyroid diseases, monitoring, and treatment, because they are best correlated with thyroid status (3, 7) .
Most clinical laboratories measure free T 4 (FT 4 ) and free T 3 (FT 3 ) by automated immunoassays (IAs) (7) (8) (9) (10) . The analytical performance of IAs has been questioned (11 ) . Significant biases have been reported due to either endogenous factors (e.g., abnormal binding proteins, dialyzable protein binding competitors, heterophile antibodies, autoantibodies) or in vitro factors (free fatty acids, assay antibodies, analogs, intrinsic dilution). Disagreement between results from different methods has been a perplexing problem, limiting their clinical utility (12, 13 ) .
An ideal method to measure free thyroid hormones should employ a separation step to physically separate the free fraction from the protein-bound fraction before quantitative analysis. The separation step should not disturb the endogenous equilibrium (9, 14 ) . Theoretically, both equilibrium dialysis (ED) and ultrafiltration (UF) can be valid methodologies. RIA of thyroid hormones in dialysate (15) (16) (17) or ultrafiltrate (18, 19 ) has been considered the reference methodology. Variability can occur in both separation and detection steps, however, resulting in significant differences among results by different UF-or ED-RIA methods (14 ) . The major concerns with UF include nonequilibrium, absorption, protein leakage, and temperature control, and with ED, dilution and dialysis buffer composition (14 ) . A procedure based on ED combined with determination of thyroxine in the dialysate with a trueness-based measurement procedure has been proposed for a candidate international conventional reference measurement (20, 21 ) .
Isotope dilution mass spectrometry (ID-MS) could be a superb detection method for thyroid hormones with high specificity in comparison to RIA or IA. Methods based on gas chromatography (GC) and ID-MS with selected ion monitoring (SIM) have been developed to measure total T 4 and T 3 , but they require laborious sample cleanup and derivatization (22) (23) (24) (25) (26) . Several methods have been reported using liquid chromatography (LC) coupled to MS in SIM mode, or tandem mass spectrometry (MS/MS) in multiple reaction monitoring (MRM) mode, to measure total T 4 (27) (28) (29) and total T 3 (29, 31 ) . Soldin et al. (32 ) reported the first method for FT 4 using UF and LC-MS/MS. T 4 in ultrafiltrates was trapped on a short C-18 column and eluted with a steep methanol gradient (up to 100%) using MRM detection in the negative ion mode with a sample cycle time of approximately 10 min. For FT 4 measurement, major concerns include no pH adjustment, UF at 25°C rather than 37°C, high ultrafiltrate yield, 2 H 2 -T 4 as internal standard (IS), protein leakage, absorption, and potential interferences. Recently, van Uytfanghe et al. (33 ) reported the first method for FT 4 using ED-LC-MS/MS as a candidate reference measurement procedure (34 ). The dialysate, with 13 C 6 -T 4 as IS and 13 C 9 -T 4 as carrier, was purified using solid-phase extraction (SPE). A 15-cm C-18 column provided 16-min LC separation before detection in positive MRM mode.
We report here a rapid and selective LC-MS/MS method with an analytically and clinically valid ED procedure for quantifying FT 4 and FT 3 in serum (see Supplemental Data for reverse T 3 ).
Materials and Methods

MATERIALS
L-Thyroxine (Ͼ98% by HPLC), trifluoroacetic acid (Ն99.0%), NH 4 OH (29.7% as NH 3 ), NaCl, Na 3 PO 4 , Na 2 HPO 4 , KH 2 PO 4 , KCl, MgSO 4 ⅐ 7H 2 O, HEPES (free acid), urea, CaCl 2 , NaN 3 , and NaOH were purchased from Sigma-Aldrich, and were of the highest purity available unless otherwise specified. We purchased T 3 (Ͼ99% by HPLC) and rT3 (Ͼ98% by TLC) from EMD Bioscience and 13 C 6 -T 4 (L-thyroxine, 99% tyrosinering-13 C 6 purity, 90%) from Cambridge Isotope Laboratories. The impurities (T 4 , T 3 , and rT3) in 13 C 6 -T 4 were found to be insignificant. We obtained acetonitrile (Optima), methanol (Optima), and formic acid (99%) from Fisher Scientific.
We prepared stock solutions of T 4 , T 3 , rT3, and We obtained the 96-well dialysis plate from Harvard Apparatus. It is designed to use a dialysand to dialysate ratio of 1:1 and up to 200 L in each compartment. Each well has its own regenerated cellulose membrane (5 kDa molecular weight cutoff). The procedure for preparing the dialysis buffer is described in the on-line Supplemental Data file. The Institutional Review Board of the University of Utah approved all studies with samples from human subjects.
SAMPLE PREPARATION
Aliquots of 200 L serum samples or quality controls were dialyzed against 200 L dialysis buffer at 37°C for approximately 20 h. Dialysate (150 L) was mixed with 150 L IS working solution in a 96-well polypropylene plate (Phenomenex).
ON-LINE SPE-LC-MS/MS
The instrument consisted of an API 5000 triple-quadrupole mass spectrometer from Applied Biosystems/ MDS Sciex, 2 1100-series binary pumps and 1 column oven from Agilent, a HTC PAL autosampler from Leap Technologies, and a 6-port switching valve from Valco Instruments Co. The LC pumps were reconfigured to reduce gradient delay volume. The switching valve was connected like an injector with an extraction column in place of the sample loop, without backing flushing.
We used a guard column of wide-pore C5 (8 by 2 mm; Phenomenex) for on-line SPE at ambient temperature with 10 mmol/L formic acid in water (A) and methanol (B) as mobile phase, and a Synergy Polar-RP column (2 m, 100 Å, 50 by 2 mm; Phenomenex) with 
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10 mmol/L formic acid in water (A) and acetonitrile (B) for LC separation at 45°C. Mobile phase for online SPE was delivered at 2 mL/min with the following program: 15% B for 0.1 min, linear ramp to 95% B in 0.6 min and hold for 0.8 min, linear ramp to 15% B in 0.3 min and hold for 0.7 min. Mobile phase for LC separation was delivered at 0.75 mL/min with the following program: 30% B for 0.6 min, linear ramp to 42.5% B in 1.6 min, linear ramp to 95% B in 0.1 min and hold for 0.2 min. At 0.6 min after injection, the switching valve was switched for 0.3 min to elute the analytes from the extraction column to the LC column. The injection volume was 250 L.
The MS instrument was operated in positive MRM mode. Two transitions were monitored for each compound: m/z 777.7-731.6 and 604.7 for T 4 ; m/z 651.8 -605.8 and 478.8 for T 3 and rT3; and m/z 783.8 -737.8 and 610.7 for IS. Chromatograms acquired from a patient serum sample are illustrated in Fig. 1 .
EVALUATION OF METHOD PERFORMANCE
All experiments described include the ED procedure, except when explicitly stated as "ED not included," and all replicates were separate preparations instead of multiple measurements from 1 preparation. To determine the lower and upper limit of quantification (LLOQ and ULOQ), we analyzed freshly spiked PBS (0.5, 1.0, 2.0, 100, 150, 200, 400 ng/L) in triplicate in each run, in 3 runs and 3 days, without the dialysis step. We evaluated imprecision by analyzing 7 serum pools in triplicate in each run, in 6 runs and 6 days. We also studied imprecision with spiked dialysis buffer (half HEPES concentration) at 3 concentrations, without the dialysis step, analyzed in triplicate in each run, in 5 runs and 5 days.
We evaluated ion suppression using a postcolumn infusion method (35 ) . A standard solution (10 g/L) was introduced into the flow path after the analytical column, resulting in an increased baseline for every transition. A set of 24 dialyzed patient samples (with low thyroid hormone concentrations) were injected. We examined the chromatograms for evidence of ion suppression. We searched 3 databases (CAS Chemical Registry, METLIN Metabolite Database, and Merck Index) were searched for compounds potentially interfering with T 4 and T 3 /rT3 and further investigated the potential interferences by examining chromatograms and quantitative results of patient samples acquired with 2 different transitions (36 ) for each compound (n Ͼ 1000).
For stability studies, aliquots of 2 serum pools were stored at ambient temperature, 4°C, and Ϫ20°C for 6 days and analyzed in duplicate in each run, in 6 runs and 6 days. The aliquots stored at Ϫ20°C were frozen and thawed 6 times. Another 4 serum pools were processed in 8 replicates and stored at ambient temperature. For 4 consecutive days, 2 replicates of 8 were analyzed each day in 1 run to study the stability of processed samples. We evaluated carryover by injecting a negative control after spiked samples containing 400 ng/L T 3 , rT3, or T 4 . We studied the effect of the serum volume used for dialysis by dialyzing 100, 150, or 200 L of 4 patient sera with 200 L dialysis buffer in duplicate in each run, in 3 runs and 3 days. 4 and FT 3 immunoassays (Roche). Another set of 30 serum samples were used for comparison with a tracer dialysis method (Quest Diagnostic).
METHOD COMPARISON
We used 3 different sets of serum samples because sample volumes were not sufficient for all comparison methods. For FT 4 comparison, we used a set of 90 serum samples previously analyzed by an ED-RIA method (Nichols Institute Diagnostics) and stored at Ϫ70°C for approximately 1 year. Another set of 96 serum samples was collected for comparison with the Vitros ECi FT 4 immunoassay (Ortho Diagnostics) and Modular Analytics E170 FT
REFERENCE INTERVALS
We followed the CLSI guideline (C28-A2). Serum samples were collected from a total of 150 healthy adults and analyzed for thyroid-stimulating hormone (TSH). We excluded 13 samples because of abnormal TSH and used 137 (67 female, 70 male) samples with normal TSH concentrations (0.3-4.0 mU/L) to establish reference intervals for free thyroid hormones. Serum samples from 818 pregnant women were collected and analyzed to establish reference intervals by week of gestation. Ethnicity was 12% Asian, 23% black, 25% Hispanic, and 41% white; ages ranged from 13.3 to 45.4 years; gestation duration was 14 to 20 weeks. All samples were anti-Tg and anti-TPO negative, with TSH between 0.15 and 3.11 mU/L as described by La'ulu et al. (37 ) . Statistical data analysis was performed with EP Evaluator (v. 7.0; David G. Rhoads Associates) and Excel (Microsoft).
Results
For FT 4 and FT 3 , the LLOQ was 1.0 ng/L (pg/mL) and the ULOQ was Ͼ400 ng/L using criteria of Ϯ15% for inaccuracy of single measurement and within-run mean against expected concentrations and within-run, between-run, and total imprecision. With serum pools, the within-run, between-run, and total imprecision (%CV) values were 2.11% to 5.56%, 2.51% to 5.00%, and 3.95% to 7.48% for FT 4 ranging from 2.44 to 53.77 ng/L and 3.71% to 6.14%, 5.49% to 10.30%, and 6.84% to 11.13% for FT 3 ranging from 2.01 to 12.28 ng/L.
With spiked dialysis buffer without the dialysis step, the within-run, between-run, and total imprecision were 1.54% to 5.30%, 2.70% to 8.21%, and 3.61% to 8.80% for FT 4 ranging from 2.00 to 35.00 ng/L and 2.86% to 5.67%, 6.89% to 9.21%, and 8.28% to 10.02% for FT 3 ranging from 2.00 to 35.00 ng/L.
For FT 4 and FT 3 , serum samples were stable for all conditions evaluated for 6 days, and no degradation 
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was detected after 6 freeze-thaw cycles (single-factor ANOVA, P value Ͻ0.1 and Ͼ0.05 with ␣ ϭ 0.05). The differences from the initial concentrations were Ͻ10% at all storage time points (P value Ͻ0.1 and Ͼ0.05 with ␣ ϭ 0.05) for the processed samples stored at ambient temperature for 4 days. It is worth pointing out that the sera used to make the pools for these 2 studies were not freshly collected, were in Ϫ80°C storage for about 1 year, and may have undergone multiple freeze-thaw cycles.
Mean carryover was Ͻ0.09% and Ͻ0.04% for FT 4 and FT 3 , respectively, in 3 runs. For FT 4 There was no evidence of ion suppression observed on the chromatograms close to the retention times of T 4 , T 3 , and 13 C 6 -T 4 . In 3 database searches, we produced a list of potential interfering compounds; however, all compounds were eliminated for interference study because they were not commercially available and not likely to be present in human serum. No evidence of interference was observed for all analytes and the IS in the results of Ͼ1000 patient samples. We performed evaluations for interferences by examining peak shape, split peak, peak shoulder, and peak area ratio of the 2 transitions (36 ) acquired for each compound. No interfering compounds have been identified to date.
Results for method comparison are illustrated in Fig. 2 for FT 4 and Fig. 3 for FT 3 . Percentage bias plots for both FT 4 and FT 3 are presented in Fig. 4 . The observed correlation between FT 4 and FT 3 was y (FT 3 ) ϭ 0.22x (FT 4 ) ϩ 1.57, S y x ϭ 5.45, r ϭ 0.87, n ϭ 96 by the described method. The reference interval for normal 
adults was established as 12.8 (95% CI, Ͻ11.7 to 13.6) to 22.2 (20.2 to Ͼ28.6) ng/L for FT 4 and 3.62 (Ͻ3.11 to 4.14) to 6.75 (6.60 to Ͼ7.05) ng/L for FT 3 using nonparametric method (CLSI C28-A). One sample was observed with exceptionally high FT 4 (28.6 ng/L) and marginal FT 3 (6.6 ng/L). For 13 samples excluded with abnormal TSH, a range of 12.4 -19.4 ng/L was obtained for FT 4 and 4.79 -7.95 ng/L for FT 3 . The reference intervals for pregnant women in the second trimester are presented by week of gestation in Table 1 .
Discussion
ON-LINE SPE-LC-MS/MS
The on-line SPE setup was similar to a 2-dimensional LC because both on-line SPE and LC separation were performed with gradient elution. The wide-pore C5 extraction column was chosen from different stationary phases studied (C1, C5, C8, CN, and Phenyl). The retention properties of the C5 guard column matched the analytical LC column (ether-linked phenyl with polar endcapping) so that T 4 , T 3 , and rT3 can be quickly and completely eluted onto the LC column in Ͻ0.3 min. The chromatographic focusing in the gradient elution, combined with 2.5-m LC packing, produced very narrow peaks (approximately 0.15-min peak width on baseline) despite the large injection volume of 250 L (Fig. 1) . Completely resolved peaks were obtained for T 4 , T 3 , and rT3. Thorough cleanup by on-line SPE with high-efficiency LC separation and specific MRM detection provided high selectivity, as demonstrated by the absence of ion suppression and interferences in patient samples.
Moreover, the LC column equilibration critical for the gradient method was performed during sample loading and washing of the extraction column, and cleaning and equilibration of the extraction column were performed during the chromatographic separation on the analytical column. A throughput of 480 samples per day could be achieved with Ͻ3.0 min cycle time. Compared to manual SPE, the advantages of this method include simplicity, high recovery, specificity, and throughput.
SAMPLE PREPARATION
See Supplemental Data for studies related to sample preparation procedure, dialysis buffer preparation, and absorption loss in preparing standard solutions onto the 96-well polypropylene plate and the 96-well dialysis plate.
Protein leakage through the membrane, with spuriously high results, was observed during method development. It was the result of the membrane being pierced by pipette tips during sample handling, not defective devices. The 5-kDa molecular weight cutoff of the regenerated cellulose membrane used in the dialysis plate is low enough to stop proteins from diffusing through, consistent with several studies indicating that the dialysates are free from protein leakage (15, 38, 39 ) . The on-line SPE-LC method is sensitive to the presence of proteins in the dialysate, which results in clogging the LC column or reduced retention time. These symptoms may serve as indicators of the protein leakage into the dialysate. In more than 6 months of routine operation, and Ͼ3000 samples analyzed in duplicate, protein leakage has not been observed with dialysis plates from different batches.
At least 2 factors are responsible for the increased concentrations of free hormones when lower sample volumes are used for dialysis. First, it is equivalent to a larger dilution if dialyzing less serum volume against a constant volume of buffer, and dilution has a complex effect on the obtained results (14, 15, 40 ) . More importantly, the dialysand/dialysate should have a lower pH with the lower serum volume. It was confirmed that lower pH was associated with the higher results for free thyroid hormones (see Supplemental Data).
PERFORMANCE EVALUATION
The CVs obtained with spiked dialysis buffers were similar to serum pools, implying that insignificant imprecision was introduced by the dialysis step. This is consistent with the fact that ED is a separation step, not a quantitative step. Two forms of matrix effect, ion suppression and interferences, could severely impact the performance and usage of a LC-MS/MS method. Different means to reduce matrix effects include high-efficiency separation and thorough sample clean-up as used in the described method. Several protocols have been developed to study the presence of ion suppression (35 ) . For a LC-MS/MS method, a potential interfering compound has to satisfy at least 3 criteria: first, it must at least partially coelute with the analyte; second, its ions, including any isotope series or any kind of adduct ions, must share the same m/z as the analyte/adduct ions under the ionization mode used; third, its ions must share the fragment ions chosen for the analyte. Thus, a list of potential interfering compounds can be generated by searching chemical databases and evaluating the probability of their presence in real samples. This approach, and monitoring 2 MRM transitions (36 ), showed no interferences in the analysis of Ͼ1000 patient samples by the described method.
METHOD COMPARISON
There was no full agreement observed with any method compared for FT 4 or FT 3 (Fig. 2, 3, and 4) . However, overall comparison strongly supports the validity of the reported method. A slope of 0.99 was obtained compared with the ED-RIA method. In the lower concentration ranges, excellent correlation was obtained for FT 4 (E170 and Vitros ECi) and FT 3 (E170), with a small intercept, correlation coefficient (r) close to unity, and small S y x , although a slope difference from unity could be explained by method calibration. Saturation of antibody was suspected in both E170 and Vitros ECi immunoassay for FT 4 ; however, it was not observed with FT 3 , possibly due to much lower endogenous concentrations of FT 3 than FT 4 . The presence of large discrepancies between methods (especially ED-RIA for FT 4 ) could be explained by individual method design and performance. For example, the dilution effect (1:1 vs 1:12 serum-to-buffer ratio) could in part explain the large scattering of data points compared with the ED-RIA method (see section for dialysis buffer in Supplemental Data).
REFERENCE INTERVALS
The narrow normal distribution of FT 4 and FT 3 for the reference interval study is in agreement with tight control by the hypothalamus-pituitary-thyroid axis (1, 2 ) . However, one exceptionally high FT 4 was observed with a normal FT 3 and TSH. The 13 samples rejected by TSH for reference interval study produced FT 4 results within the established reference interval, whereas FT 3 shifted toward the upper normal range. Furthermore, FT 4 and FT 3 poorly correlated. The above observations suggest the differences in clinical relevance of FT 4 , FT 3 , and TSH (1, 2 ) . Results of the reference interval study in pregnant women suggest a shift toward lower values of FT 4 and FT 3 compared with normal adults. There is a small trend toward lower values of FT 4 from week 14 to week 20 of gestation.
Conclusions
We developed a simple protein-free buffer and ED procedure for free thyroid hormones in serum. All critical technical aspects (C-45A guideline), including buffer composition, dialysate pH, absorption, and dilution (serum-to-buffer ratio), were thoroughly studied and optimized. We also developed a fast, accurate, selective, and high-throughput LC-MS/MS method to quantify the thyroid hormones in dialysates. Method comparison studies support the analytical and clinical validity of this method. Method performance was sufficient for intended clinical utility (LLOQ, 1 ng/L, sample cycle time Ͻ3 min).
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